A. Castonguay

发表

Metabolism of carcinogenic amino derivatives in various species and DNA alkylation by their metabolites.

H. Schut, A. Castonguay, Herman A.J. Schut, 1984, Drug metabolism reviews.

Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa.

S. Hecht, E. Brittebo, A. Castonguay, 1983, Cancer research.

Modulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1 butanone demethylation and denitrosation by rat liver microsomes.

N. Brière, P. Pépin, A. Castonguay, 1991, Cancer letters.

Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.

J. Cloutier, R. Drouin, T. O'Connor, 2001, Journal of molecular biology.

Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice.

F. Chung, J. Bilodeau, A. Castonguay, 1995, Free radical biology & medicine.

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.

A. Castonguay, N. Rioux, 1998, Carcinogenesis.

Cytokine production by alveolar macrophages is down regulated by the alpha-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

E. Bissonnette, A. Castonguay, L. Proulx, 2004, Carcinogenesis.

Acetylsalicylic Acid and NS-398 Prevention of NNK-induced Lung Tumorigenesis in A/J Mice by

A. Castonguay, N. Rioux, 2013 .

Immunomodulatory effects of the tobacco‐specific carcinogen, NNK, on alveolar macrophages

E. Bissonnette, A. Castonguay, L. Proulx, 2003, Clinical and experimental immunology.

Ki‐ras mutations in 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone—initiated and butylated hydroxytoluene—promoted lung tumors in A/J mice

M. You, W. Gunning, A. Castonguay, 1994, Molecular carcinogenesis.

Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine.

S. Hecht, A. Castonguay, A. Rivenson, 1986, Cancer research.

Repair kinetics of specific types of nitroso-induced DNA damage using the comet assay in human cells.

R. Drouin, A. Castonguay, S. Lacoste, 2007, Mutation research.

4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells

E. Bissonnette, A. Castonguay, M. Gaudreault, 2005, Clinical and experimental immunology.

Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.

M. You, B. Chen, R. Maronpot, 1993, Carcinogenesis.

Tobacco-specific nitrosamines in Canadian cigarettes

B. Spiegelhalder, A. Castonguay, R. Preussmann, 2005, Journal of Cancer Research and Clinical Oncology.

Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.

G. B. Smith, T. Massey, A. Castonguay, 1999, Carcinogenesis.

Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

A. Castonguay, N. Rioux, 1998, Cancer research.

Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.

M. You, A. Castonguay, N. Rioux, 2000, Experimental lung research.

Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice.

A. Castonguay, C. Duperron, Caroline Duperron, 1997, Carcinogenesis.

Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis.

A. Castonguay, N. Rioux, C. Duperron, 1998, Experimental lung research.

Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs.

A. Castonguay, N. Rioux, 1997, Journal of the National Cancer Institute.

Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice.

A. Castonguay, G. Jalbert, Andre Castonguay, 1992, Cancer letters.

Effects of α-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)1

S. Hecht, A. Castonguay, D. Lin, 1983 .

Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidin.

M. Boukharta, T. Hatano, T. Okuda, 1997, International journal of oncology.

Absence of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by flavin-containing monooxygenase (FMO).

A. Castonguay, J. Lamoureux, 1997, Carcinogenesis.

Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds.

R. Teel, A. Castonguay, C. Miller, 1996, Mutation research.

Antimutagenic effects of polyphenolic compounds.

R. Teel, A. Castonguay, 1992, Cancer letters.

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid.

A. Castonguay, M. Boutet, M. Charest, 1989, Cancer letters.

Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes.

A. Castonguay, K. Demkowicz-Dobrzański, 1992, Carcinogenesis.

The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB.

A. Castonguay, N. Rioux, Andre Castonguay, 2000, Carcinogenesis.

Radioimmunoassay of N'-nitrosonornicotine.

A. Castonguay, H. Van Vunakins, 1979, Analytical biochemistry.

Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues.

S. Hecht, G. Stoner, J. Klaunig, 1983, Cancer research.

Tissue distribution of the tobacco-specific carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats.

S. Hecht, H. Tjälve, A. Castonguay, 1983, Cancer research.

Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57BL mice.

S. Hecht, H. Tjälve, A. Castonguay, 1984, Journal of the National Cancer Institute.

Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.

S. Hecht, D. Hoffmann, A. Castonguay, 1981, Cancer research.

Metabolism of tobacco-specific N-nitrosamines by cultured human tissues.

S. Hecht, G. Stoner, H. Schut, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Effects of alpha-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

S. Hecht, A. Castonguay, D. Lin, 1983, Carcinogenesis.

Kinetics of DNA methylation by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats.

S. Hecht, A. Castonguay, R. Tharp, 1984, IARC scientific publications.

Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats.

S. Hecht, A. Castonguay, A. Rivenson, 1984, Cancer research.

Metabolism, sister chromatid exchanges, and DNA single-strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their modulation by vitamin A in vitro.

M. Alaoui-Jamali, A. Castonguay, P. Bélanger, 1991, Cancer research.

Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine in hamster lung.

H. Schuller, A. Castonguay, M. Orloff, 1991, Cancer research.

Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung.

P. Pépin, A. Castonguay, P. Nicole, 1992, Carcinogenesis.

Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice.

M. Boukharta, A. Castonguay, G. Jalbert, 1992, Nutrition and cancer.

Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

H. Schuller, H. Schüller, A. Castonguay, 1993, Cancer research.

On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking.

J. Adams, D. Hoffmann, A. Castonguay, 1983, Cancer letters.

The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters.

H. Schuller, H. Schüller, A. Castonguay, 1990, Cancer research.

Study of DNA methylation by tobacco-specific N-nitrosamines.

S. Hecht, A. Castonguay, P. Foiles, 1985, Environmental health perspectives.

Comparative Carcinogenicity in A/J Mice and Metabolism by Cultured Mouse Peripheral Lung of AT-Nitrosonornicotine, and Their Analogues1

S. Hecht, G. Stoner, J. Klaunig, 2006 .

Modulation of DNA repair by various inhibitors of DNA synthesis following 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced DNA damage.

J. Cloutier, A. Castonguay, 1998, Chemico-biological interactions.

Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin.

A. Castonguay, L. Liu, 1991, Carcinogenesis.

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).

L. Dwyer-Nield, A. Malkinson, G. Piazza, 1998, Carcinogenesis.

Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

A. Castonguay, N. Rioux, Andre Castonguay, 1997, Carcinogenesis.

Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes.

H. Schuller, A. Castonguay, R. Jorquera, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters.

H. Schuller, A. Castonguay, R. Jorquera, 1992, Cancer research.

Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster.

M. Alaoui-Jamali, H. Schuller, A. Castonguay, 1989, Cancer research.

Dietary Modulation of Tobacco-Specific Carcinogen Activation

P. Pépin, M. Alaoui-Jamali, A. Castonguay, 1990 .

In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues.

A. Castonguay, M. Charest, G. Rossignol, 1989, Chemico-biological interactions.

Effects of Chronic Ethanol Consumption on the Metabolism and Carcinogenicity of W-Nitrosonornicotine in F344 Rats1

S. Hecht, A. Castonguay, A. Rivenson, 2006 .

Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.

M. Alaoui-Jamali, A. Castonguay, L. Liu, 1990, Cancer research.

Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine.

M. Alaoui-Jamali, A. Castonguay, R. Gagnon, 1990, Mutation research.

[49] Radioimmunoassays for N′-acylnornicotine and N′-acylnornicotine analogs

A. Castonguay, H. Vunakis, 1982 .

Nitrosation and transnitrosation of nornicotine: inhibitory effect of some antioxidants

A. Castonguay, H. Vunakis, 1979 .

Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus).

G. Sperber, H. Tjälve, G. Sperber, 1985, Carcinogenesis.

The in vivo tissue disposition and in vitro target-tissue metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Syrian golden hamsters.

H. Tjälve, A. Castonguay, 1983, Carcinogenesis.

Expression of the cytochrome P4502E and 2B gene families in the lungs and livers of nonpregnant, pregnant, and fetal hamsters.

M. Miller, H. Schüller, A. Castonguay, 1992, Biochemical pharmacology.

Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats.

S. Hecht, A. Castonguay, A. Rivenson, 1987, Carcinogenesis.

Immunoassays for proteins alkylated by nicotine-derived N-nitrosamines

B. Talbot, S. Desnoyers, A. Castonguay, 2005, Archives of Toxicology.

Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in cultured explants and epithelial cells of human buccal mucosa.

S. Belinsky, R. Grafström, H. Tjälve, 1993, Carcinogenesis.

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA.

M. Desrochers, A. Castonguay, A. Anderson, 1993, Carcinogenesis.

Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

S. Gerson, A. Castonguay, L. Liu, 1992, Carcinogenesis.

Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes.

H. Schuller, A. Castonguay, R. Jorquera, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Reactions with Deoxyguanosine of 4-(Carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, a Model Compound for α-Hydroxylation of Tobacco-Specific Nitrosamines

S. Hecht, A. Castonguay, D. Lin, 1986 .

Microautoradiographic localization of bound metabolites in the nasal cavities of F344 rats treated with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

H. Tjälve, A. Castonguay, A. Rivenson, 1985, Journal of the National Cancer Institute.

Effects of age and ethanol on DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or n-nitrosodimethylamine in hamster and rat liver.

H. Schuller, A. Castonguay, R. Jorquera, 1993, Cancer letters.

Measurement of O6-methyldeoxyguanosine in DNA methylated by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone using a biotin-avidin enzyme-linked immunosorbent assay.

A. Castonguay, P. Foiles, N. Trushin, 1985, Carcinogenesis.

of the Syrian Golden Hamster 4-( Methylnitrosamino )-1-( 3-pyridyl )-1-butanone in Fetal Tissues Metabolism and DNA Damage Induced by Updated Version

M. Alaoui-Jamali, H. Schuller, A. Castonguay, 2006 .

Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue.

R. Teel, M. Boukharta, A. Castonguay, 1998, Chemical research in toxicology.

Synthesis of carbon‐14 labeled 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone

S. Hecht, A. Castonguay, 1985 .

C-Alkylation of 1,3-dihydroxyanthraquinones. Total syntheses of (±)-averufin and (±)-bipolarin

A. Castonguay, P. Brassard, 1977 .

The carbon‐13 nuclear magnetic resonance spectra of anthraquinone, eight polyhydroxyanthraquinones and eight polymethoxyanthraquinones

Y. Berger, A. Castonguay, 1978 .

Carbon-13 nuclear magnetic resonance studies of anthraquinones Part II—hydroxymethoxyanthraquinones, acetoxymethoxyanthraquinones and naturally occuring anthraquinone analogues†

Y. Berger, A. Castonguay, P. Brassard, 1980 .

Strain A/J Mouse Lung Adenoma Growth Patterns Vary When Induced by Different Carcinogens

G. Stoner, P. Goldblatt, W. Gunning, 1991, Toxicologic pathology.

C-ALKYLATION OF 1,3-DIHYDROXYANTHRAQUINONES. TOTAL SYNTHESIS OF (.+-.)-AVERUFIN AND (.+-.)-BIPOLARIN

A. Castonguay, P. Brassard, 1977 .

Reduction potentials of imine-substituted, biologically active pyridines: possible relation to activity.

P. Kovacic, A. Castonguay, W. Kem, 1990, Free radical research communications.

REACTIONS OF KETENE ACETALY PART 5, THE REACTION WITH P‐BENZOQUINONE DIHALIDES

A. Castonguay, P. Brassard, 1975 .

Synthesis of (±)-averufanin,noraverufanin and bis-deoxyaverufanin

Y. Berger, A. Castonguay, 1979 .

Carbon‐13 nuclear magnetic resonance studies of anthraquinones. IV—correlation of substituent effects for 1‐substituted anthraquinones

Y. Berger, A. Castonguay, M. Berger-Deguée, 1981 .

Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA.

J. Cloutier, R. Drouin, T. O'Connor, 2001, Journal of molecular biology.

Treatment of human cells with N-Nitroso(acetoxymethyl)methylamine: distribution patterns of piperidine-sensitive DNA damage at the nucleotide level of resolution are related to the sequence context.

J. Cloutier, R. Drouin, A. Castonguay, 1999, Chemical research in toxicology.

Chlamydomonas reinhardtii as a plant model system to study mitochondrial complex I dysfunction

P. Hamel, A. Castonguay, T. A. Fatnes, 2020, Plant direct.

Tobacco specific nitrosamines: Carcinogenicity, metabolism, and possible role in human cancer

S. Hecht, D. Hoffmann, A. Castonguay, 1983 .

Optimal conditions to use Pfu exo(-) DNA polymerase for highly efficient ligation-mediated polymerase chain reaction protocols.

J. Cloutier, R. Drouin, A. Castonguay, 2001, Nucleic acids research.

The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK

M. Miller, H. Schuller, A. Castonguay, 2002, Journal of Cancer Research and Clinical Oncology.

Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters

H. Schuller, H. Schüller, A. Castonguay, 2005, Journal of Cancer Research and Clinical Oncology.

DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver.

H. Schuller, A. Castonguay, R. Jorquera, 1994, Carcinogenesis.

Assembly of Mitochondrial Complex I Requires the Low-Complexity Protein AMC1 in Chlamydomonas reinhardtii

C. Remacle, P. Hamel, A. Castonguay, 2020, Genetics.

Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster.

M. Alaoui-Jamali, H. Schuller, A. Castonguay, 1989, Mutation research.

Low levels of expression of cytochromes P-450 in normal and cancerous fetal pancreatic tissues of hamsters treated with NNK and/or ethanol.

P. Thomas, M. Miller, H. Schuller, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies.

G. Stoner, P. Pépin, A. Castonguay, 1991, Experimental lung research.

In vitro morphological changes induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-(butanone) in fetal hamster respiratory tract tissue.

H. Schuller, A. Castonguay, G. Rossignol, 1989, Cancer letters.

Carcinogenicity, metabolism and DNA binding of the tobacco specific nitrosamine, 4-(methylnitrosamino)-1-3(3-pyridyl)-1-butanone (NNK)

S. Hecht, D. Hoffmann, A. Castonguay, 1981 .

Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes.

A. Castonguay, K. Demkowicz-Dobrzański, 1991, Carcinogenesis.

Chemical carcinogenesis, mutagenesis, and teratogenesis.

F. Guengerich, B. Hales, P. O'Brien, 1996, Canadian journal of physiology and pharmacology.

Study of Chemical Carcinogenesis. Part 91. Reactions with Deoxyguanosine of 4-(Carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, a Model Compound for α-Hydroxylation of Tobacco-Specific Nitrosamines.

S. Hecht, A. Castonguay, D. Lin, 2002 .

Synthesis of nornicotine analogs to use as haptens for immunoassays

A. Castonguay, H. Vunakis, 1979 .

In vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by lung cells isolated from Syrian golden hamster.

T. Massey, M. Alaoui-Jamali, A. Castonguay, 1990, Cancer letters.

Effects of Ethanol Consumption on the Metabolism and Carcinogenicity of N′‐Nitrosonornicotine in F344 Rats a

S. Hecht, A. Castonguay, A. Rivenson, 1984 .

Modulation of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver microsomes to protein alkylating species.

A. Castonguay, G. Rossignol, 1992, Toxicology in vitro : an international journal published in association with BIBRA.

Carcinogenicity and metabolic activation of tobacco-specific nitrosamines: current status and future prospects.

S. Hecht, F. Chung, D. Hoffmann, 1984, IARC scientific publications.

Formamidopyrimidine adducts are detected using the comet assay in human cells treated with reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

R. Drouin, A. Castonguay, S. Lacoste, 2006, Mutation research.

Pulmonary Carcinogenesis and Its Prevention by Dietary Polyphenolic Compounds a

A. Castonguay, 1993, Annals of the New York Academy of Sciences.

Induction of COX expression by a tobacco carcinogen: Implication in lung cancer chemoprevention

A. Castonguay, N. Rioux, 1999, Inflammation Research.

Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants.

A. Castonguay, L. Bouchard, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Assay of 1-nitropropane, 2-nitropropane, 1-azoxypropane and 2-azoxypropane for carcinogenicity by gavage in Sprague-Dawley rats.

E. Fiala, A. Castonguay, A. Rivenson, 1987, Carcinogenesis.

Distrubution and metabolism in syrian golden hamsters of 4=(methylnitrosamino)=1=(3=pyridyl)=1= butanone (NNK), a tebacco-specific careinogen

H. Tjälve, A. Castonguay, 1983 .

Nasal Cavity Rhabdomyosarcoma (NCR) in Rats Treated with Tobacco‐Specific N‐Nitrosamines (TSNA) a

A. Castonguay, A. Rivenson, B. Mu, 1984 .

Localization of bound metabolites in the respiratory tissues and oesophagus by high-resolution microautoradiography in Fischer 344 rats treated with N'-nitrosonornicotine.

H. Tjälve, A. Castonguay, 1987, IARC scientific publications.

Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis

C. Beauchemin, E. Dellon, B. Feagan, 2021, Advances in Therapy.

In vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone activated by hamster maternal and fetal tissues.

M. Alaoui-Jamali, H. Schuller, A. Castonguay, 1988, Carcinogenesis.

Distribution and metabolism in Syrian golden hamsters of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen.

H. Tjälve, A. Castonguay, 1983, Developments in toxicology and environmental science.